Title : New generation anaplastic lymphoma kinase inhibitors.

Pub. Date : 2019 Nov

PMID : 31857951






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The therapeutic strategy depends on anti-ALK tyrosine kinase inhibitors (TKIs) of which crizotinib was the first approved for clinical use. crizotinib ALK receptor tyrosine kinase Homo sapiens